A systematic review and meta-analysis on incidence of prostate cancer in Iran

Asaad Moradi ¹, Mohammad Zamani ^2,3 , Emadoddin Moudi ^4,5 *

Cited by CrossRef: 4

1- Shamsi M, Mirzaei M, Vaziri S, Mozaffari H. Common mistakes in reporting systematic reviews and meta-analyses. Health Promot Perspect. 2020;10(2):97 [Crossref]

2- Rasouli M, Moradi G, Zareie B, Sofimajidpour H, Tozandehjani S, Zafari H, Gholami F, Shahsavari S, Hassani P, Mohammadian M. Overall survival and prognostic factors prostate cancer in Kurdistan Province-Iran: a population-based study (2011-2018). BMC Cancer. 2021;21(1) [Crossref]

3- EyvaziNasab K, Alimohammadi A, Almasi-Hashiani A. Incidence Trend of Prostate Cancer in Markazi Province (Center of Iran), Results of Population-based Cancer Registry, and Application of Joinpoint Regression Model, 2012-2017. TOPHJ. 2023;16(1) [Crossref]

4- Rezaee M, Karimzadeh I, Hashemi-Meshkini A, Zeighami S, Bazyar M, Lotfi F, Keshavarz K. Cost-Effectiveness Analysis of Triptorelin, Goserelin, and Leuprolide in the Treatment of Patients With Metastatic Prostate Cancer: A Societal Perspective. Value in Health Regional Issues. 2024;42:100982 [Crossref]

5- Nowroozi M, Farkhani E, Hushmandi K, Amini E, Momeni S, Inanloo S, Bokaie S, Sharifi L. Trends in Incidence of Prostate Cancer in Iran and Its 31 Provinces During 2003 - 2016. Int J Cancer Manag. 2023;In Press(In Press) [Crossref]

6- Khani Jeihooni A, Amirkhani M, Mirshekari H, Kashfi S. Prostate Cancer Screening Behaviors Based on the Health Belief Model in Men Aged 40-70 Years in Fasa City, Fars Province, Iran, in 2019. PCNM. 2021;11(3):18 [Crossref]